ABCD Webinar: A clinical update on screening for type 1 diabetes

Man wearing headphones, watching webinar on laptop

This webinar will provide healthcare professionals a clinical update on screening for type 1 diabetes.

This webinar will offer practical advice and help you to:

  • Understand the rationale and current state of development for screening, including who might be considered.
  • Understand available and emerging screening approaches and staging, and how to interpret results to estimate risk.
  • Understand the potential benefits, risks and practical implications of screening to support informed, equitable decisions.

Please note: Certificates of attendance will be issued to those who attend the live webinar.

This webinar has been instigated and organised by ABCD. The support from our corporate sponsors has allowed us to provide this valuable educational meeting free of charge to all delegates. Sponsors have had no input into the agenda or the selection of speakers.

Speakers

  • Dr. Rachel Besser

    image of Dr. Rachel Besser

    Dr Rachel Besser BSc MBBS MRCPCH PhD
    Rachel is a Consultant paediatrician at Oxford Children’s Hospital and researcher at the University of Oxford, where she leads the T1Early research programme, undertaking work on screening for childhood type 1 diabetes (T1D). Rachel leads a number of initiatives in the UK and Europe on T1D screening and holds senior leadership positions, including as Diabetes officer for the British Society for Paediatric Endocrinology and Diabetes (BSPED), as Chair of the BSPED Pre-T1D Special Interest group, and co-lead of the NHS England Task & Finish group on T1D screening and Immunotherapy. She is funded by NIHR, Diabetes UK and UKRI. @BesserBesser, @T1Early // LinkedIn

  • Dr. Victoria Salem

    image of Dr. Victoria Salem

    Vicky Salem is a Senior Clinical Lecturer in Bioengineering at Imperial College London and Honorary Consultant in Diabetes, Endocrinology and Acute Medicine at Charing Cross Hospital. Her research focuses on type 2 diabetes and obesity, with a particular interest in the neuroendocrinology of the gut brain axis and advanced optical imaging platforms to interrogate pancreatic islet function in health and disease.